Today: 21 April 2026
Browse Category

ASX:NAB 6 November 2025 - 5 December 2025

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

NAB shares traded at A$40.64 on Friday, up 0.3–0.4%, after falling over 10% from a November peak near A$45.25. The stock offers a 4.2% fully franked dividend yield, backed by FY25 dividends of A$1.70 per share and a CET1 ratio of 11.7%. FY25 cash earnings were A$7.09 billion, flat year-on-year and slightly below expectations. NAB trades at 18–19 times trailing earnings, above sector averages.
National Australia Bank (ASX:NAB) Stock Outlook – December 4, 2025: Share Price, Dividend and 2026 Forecasts

National Australia Bank (ASX:NAB) Stock Outlook – December 4, 2025: Share Price, Dividend and 2026 Forecasts

NAB shares traded around A$40.40–A$40.50 intraday on 4 December, about 10% below their November peak. FY25 results showed statutory net profit fell 2.9% to A$6.76 billion, with cash earnings flat at A$7.09 billion. Loan impairment charges rose 14% to A$833 million, while non-performing loans increased to 1.55%, mainly from business banking.
National Australia Bank (ASX:NAB) Stock on 2 December 2025: Dividend Update, Share Price Outlook and 2026 Forecast

National Australia Bank (ASX:NAB) Stock on 2 December 2025: Dividend Update, Share Price Outlook and 2026 Forecast

National Australia Bank shares traded around A$40.10–A$40.12 early afternoon 2 December, with a market cap near A$123 billion. NAB confirmed a fully franked final dividend of 85 cents per share, bringing the FY25 total to 170 cents. The DRP issue price for the 12 December allotment was set at A$40.45. The stock remains about 10–12% below its early November high of A$45.25.
2 December 2025
National Australia Bank (ASX:NAB) Share Price Outlook: 2025 Earnings, Dividends and Fresh Analyst Forecasts

National Australia Bank (ASX:NAB) Share Price Outlook: 2025 Earnings, Dividends and Fresh Analyst Forecasts

National Australia Bank opened December 2025 trading near A$40, about 11% below its October high but well above April lows. FY25 results showed cash earnings flat at A$7.1 billion, with net interest income up 3.8% to A$17.4 billion. Asset quality weakened slightly, with higher credit impairment charges and more non-performing loans. Shares remain up over 20% from April’s trough.
1 December 2025
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

Australian sharemarket today: S&P/ASX 200 closes at 8,799.5, down 0.22% — CBA extends slide, Life360 tumbles; energy and materials firm

Australia’s S&P/ASX 200 closed down 0.22% at 8,799.5 on Wednesday, as losses in banks and tech outweighed gains in miners and defensives. Commonwealth Bank dropped about 3% to a seven-month low after its quarterly update. Life360 slumped further, while Mineral Resources surged on a US$765 million lithium deal with POSCO. The All Ordinaries slipped 0.21% to 9,079.4.
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

ASX Today: S&P/ASX 200 edges up 0.3% to 8,828 as gold miners shine; James Hardie halted, NAB slips — 6 Nov 2025

James Hardie shares plunged 12.7% and trading was paused after its removal from MSCI Australia indexes. The S&P/ASX 200 closed up 0.3% at 8,828.3, led by miners and gold stocks. National Australia Bank reported a flat full-year profit of A$7.09 billion. The Australian dollar traded near US$0.651.

Stock Market Today

  • CRISPR Therapeutics (CRSP) Stock Valuation Shows Steep Discount Amid Strong Returns
    April 21, 2026, 5:40 AM EDT. CRISPR Therapeutics (CRSP) stock closed at $57.69, down 0.5% in the past day but up 24.76% over 30 days and 52.54% in one year, highlighting recent momentum. The market price trades significantly below the company's estimated discounted cash flow (DCF) fair value of $185.71, indicating the stock may be undervalued based on projected future cash flows. CRISPR is a clinical-stage biotech with limited current revenue ($3.51 million) and ongoing losses of $581.6 million, emphasizing the high-risk profile tied to its pipeline's long-term potential. Price-to-book (P/B) ratio stands at 2.9, higher than the industry average of 2.5 but much lower than the 23.6 peer average, presenting a mixed valuation signal. Investors should consider regulatory risks and clinical setbacks before making decisions.

Latest article

Australia Stock Market Today: ASX 200 Stalls as Rio Tinto Gain Runs Into Energy Selloff

Australia Stock Market Today: ASX 200 Stalls as Rio Tinto Gain Runs Into Energy Selloff

21 April 2026
Australian shares closed nearly flat Tuesday, with the S&P/ASX 200 down 3.9 points to 8,949.40 as investors awaited U.S.-Iran talks. Rio Tinto rose after reporting a 9% jump in first-quarter copper-equivalent output, but energy stocks fell. Brent crude traded near $95 a barrel, and the Australian dollar slipped to $0.715. ANZ reported consumer confidence at 64.3, near record lows, with inflation expectations at 7.1%.
FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

FTSE 100 Today: British Land Rally Masks AB Foods Slide as UK Stocks Edge Up

21 April 2026
The FTSE 100 rose 0.12% to 10,622.06 in delayed London trade Tuesday, while the FTSE 250 gained 0.39%. British Land climbed after boosting earnings guidance and signing Anthropic as a tenant. Associated British Foods fell on plans to split Primark from its food units and a profit warning. Crest Nicholson plunged nearly a third after cutting its outlook and warning on home completions.
US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

US Stock Market Premarket Today: Why Nasdaq Futures Are Rising Before the Bell

21 April 2026
U.S. stock index futures rose early Tuesday, with Nasdaq 100 futures up 0.3% and Dow futures gaining 61 points, as investors weighed AI gains against Middle East tensions. Amazon announced up to $25 billion in new investment in Anthropic, while Apple said Tim Cook will step down as CEO in September, succeeded by John Ternus. The U.S. Census Bureau will release March retail sales data at 8:30 a.m. EDT.
Go toTop